CURRENT POSSIBILITIES OF ORGANIZED SCREENING FOR CANCER OF THE CERVIX UTERI
- Авторлар: Apolikhina I.A.1,2, Filippenkova E.V.1, Dodova E.G.1, Gulnara H.F.1, Gorbunova E.A.1
-
Мекемелер:
- Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University
- Шығарылым: № 9 (2016)
- Беттер: 12-19
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247725
- ID: 247725
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Inna Apolikhina
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University
Email: i_apolikhina@oparina4.ru
MD, Head of Gynecology and aesthetic rehabilitation; professor of the Department of Obstetrics, Gynecology, Perinatology, and Reproductology 117997, Russia, Moscow Ac. Oparina str. 4
Ekaterina Filippenkova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: e_filippenkova@oparina4.ru
graduate student 117997, Russia, Moscow Ac. Oparina str. 4
Elena Dodova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: adeli575@mail.ru
graduate student 117997, Russia, Moscow Ac. Oparina str. 4
Hasanova Gulnara
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: g_gasanova@oparina4.ru
graduate student 117997, Russia, Moscow Ac. Oparina str. 4
Elena Gorbunova
Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: el_gorbunova@oparina4.ru
doctor in the department of gynecology and aesthetic rehabilitation 117997, Russia, Moscow Ac. Oparina str. 4
Әдебиет тізімі
- Абакарова П.Р., Довлетханова Э.Р., Межевитинова Е.А. Значение скрининга в диагностике предрака и рака шейки матки. Эффективная фармакотерапия. 2014; 23: 6-9.
- Кулаков В.И., Прилепская В.Н., Паавонен Й. Профилактика рака шейки матки. Руководство для врачей. М.: МЕДпресс-информ; 2008
- Прилепская В.Н., Роговская С.И. Возможности Изопринозина в лечении хронических цервицитов и вагинитов. Русский медицинский журнал. 2008; 16(1): 5-9.
- WHO. Comprehensive cervical cancer control. A guide to essential practice -Second edition, 2014
- Centers for Disease Control and Prevention (CDC). Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb. Mortal. Wkly Rep. 2012; 61(15): 258-61.
- Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 2011; 32(29): 4294-301.
- Gillison M.L., Chaturvedi A.K., Lowy D.R. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008; 113(10): 3036-44.
- Slatter T.L., Hung N.G., Clow W.M., Royds J.A., Devenish C.J., Hung N.A. A clinicopathological study of episomal papillomavirus infection of the human placenta and pregnancy complications. Mod. Pathol. 2015; 28(10): 1369-82.
- Crosby R.A., Hagensee M.E., Vanderpool R., Nelson N., Parrish A., Collins T., Jones N. Community-based screening for cervical cancer: a feasibility study of rural appalachian women. Sex. Transm. Dis. 2015; 42(11): 607-11.
- Прилепская В.Н., ред. Патология шейки матки и генитальные инфекции. М.: МЕДпресс-информ; 2008.
- Доброхотова Ю.Э., Венедиктова М.Г., Гришин И.И., Саранцев А.Н., Морозова К.В., Луценко Н.Н. Эффективность комплексного подхода к лечению дисплазии эпителия шейки матки умеренной и тяжелой степени на фоне инфицирования вирусом папилломы человека. Фарматека. 2015; 3: 44-7.
- Hampson L., Martin-Hirsch P., Hampson I.N. An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia. Expert Opin. Investig. Drugs. 2015; 24(12): 1529-37.
- Andrae B., Kemetli L., Sparén P., Silfverdal L., Strander B., Ryd W. et al. Screening - preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J. Natl. Cancer Inst. 2008; 100(9): 622-9.
- Stenvall H., Wikström I., Backlund I., Wilander E. Accuracy of HPV testing of vaginal smear obtained with a novel self-sampling device. Acta Obstet. Gynecol. Scand. 2007; 86(1): 16-21.
- II Междисциплинарный форум с международным участием «Шейка матки и вульвовагинальные болезни». ВПЧ-тест - самостоятельно, доступно и при этом в сертифицированной лаборатории. Реальность XXI века. Эффективная фармакотерапия. 2014; 5: 43-9.
- Mayrand M.H., Duarte-Franco E., Rodrigues I., Walter S.D., Hanley J., Ferenczy A. et al.; Canadian Cervical Cancer Screening Trial Study Group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N. Engl. J. Med. 2007; 357(16): 1579-88.
- Mayrand M.H., Duarte-Franco E., Coutlée F., Rodrigues I., Walter S.D., Ratnam S., Franco E.L.; CCCaST Study Group. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial. Int. J. Cancer. 2006; 119(3): 615-23.
- Sanner K., Wikström I., Strand A., Lindell M., Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br. J. Cancer. 2009; 101(5): 871-4.
- Sancho-Garnier H., Tamalet C., Halfon P., Leandri F.X., Le Retraite L., Djoufelkit K. et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int. J. Cancer. 2013; 133(11): 2681-7.
- Penaranda E., Molokwu J., Flores S., Byrd T., Brown L., Shokar N. Women’s attitudes toward cervicovaginal self-sampling for high-risk HPV infection on the US-Mexico border. J. Low. Genit. Tract. Dis. 2015; 19(4): 323-8.
- Jentschke M., Chen K., Arbyn M., Hertel B., Noskowicz M., Soergel P., Hillemanns P. Comparative evaluation of two vaginal self-sampling devices for the detection of human papillomavirus infections. J. Clin. Virol. 2016; 82: 46-50.
- Racey C.S., Withrow D.R., Gesink D. Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can. J. Public Health. 2013; 104(2): e159-65.
- Darlin L., Borgfeldt C., Forslund O., Hénic E., Hortlund M., Dillner J., Kannisto P. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. J. Clin. Virol. 2013; 58(1): 155-60.
- Wikström I., Lindeil M., Sanner K., Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br. J. Cancer. 2011; 105(3): 337-9.
- Eperon I., Vassilakos P., Navarria I., Menoud P.A., Gauthier A., Pache J.C. et al. Randomized comparison of vaginal self-sampling by standard vs. dry swabs for human papillomavirus testing. BMC Cancer. 2013; 13: 353-9.
- Pathak N., Dodds J., Zamora J., Khan K. Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ. 2014; 349: g5264.
- Östensson E., Fröberg M., Leval A., Hellström A.-C., Bäcklund M., Zethraeus N., Andersson S. Cost of preventing, managing, and treating human papillomavirus (HPV)-related diseases in Sweden before the introduction of quadrivalent HPV vaccination. PLoS One. 2015; 10(9): e0139062.
- Zhu J., Norman I., Elfgren K., Gaberi V., Hagmar B., Hjerpe A., Andersson S. A comparison of liquid-based cytology and Pap smear as a screening method for cervical cancer. Oncol. Rep. 2007; 18(1): 157-60.
- Adamson P.C., Huchko M.J., Moss A.M., Kinkel H.F., Medina-Marino A. Acceptability and accuracy of cervical cancer screening using a self-collected tampon for HPV messenger-RNA testing among HIV-infected women in South Africa. PLoS One. 2015; 10(9): e0137299.